$244 Million is the total value of Ghost Tree Capital, LLC's 47 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 87.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $5,884,000 | -18.3% | 400,000 | -11.1% | 2.41% | -25.6% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $4,150,000 | -46.1% | 100,000 | -80.0% | 1.70% | -50.9% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $3,182,000 | -23.0% | 410,000 | -21.9% | 1.30% | -29.9% |
| ADHD | Sell | ALCOBRA LTD | $3,140,000 | -24.5% | 500,000 | -27.4% | 1.29% | -31.3% |
| TNXP | Sell | TONIX PHARMACEUTICALS HLDG C | $2,685,000 | +27.4% | 350,000 | -12.1% | 1.10% | +15.9% |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $2,318,000 | -18.1% | 151,630 | -13.4% | 0.95% | -25.5% |
| PCRX | Sell | PACIRA PHARMACEUTICALS INC | $2,304,000 | -29.9% | 30,000 | -62.5% | 0.94% | -36.3% |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -292,939 | -100.0% | -0.11% | – |
| BIOL | Exit | BIOLASE INC | $0 | – | -300,000 | -100.0% | -0.12% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -50,000 | -100.0% | -0.14% | – |
| UNIS | Exit | UNILIFE CORP NEW | $0 | – | -350,000 | -100.0% | -0.15% | – |
| ZSAN | Exit | ZOSANO PHARMA CORP | $0 | – | -100,000 | -100.0% | -0.18% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -0.19% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -89,231 | -100.0% | -0.21% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -6,500 | -100.0% | -0.22% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTERNATIONAL INC | $0 | – | -100,000 | -100.0% | -0.25% | – |
| Exit | BIODELIVERY SCIENCES INTL INcall | $0 | – | -106,200 | -100.0% | -0.27% | – | |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.35% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -150,000 | -100.0% | -0.50% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -65,000 | -100.0% | -0.58% | – |
| ACHC | Exit | ACADIA PHARMACEUTICALS | $0 | – | -40,000 | -100.0% | -0.60% | – |
| DSCI | Exit | DERMA SCIENCES INC | $0 | – | -300,000 | -100.0% | -0.64% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -220,000 | -100.0% | -0.68% | – |
| ASND | Exit | ASCENDIS PHARMA A/S - ADRadr | $0 | – | -97,135 | -100.0% | -0.77% | – |
| LBIO | Exit | LION BIOTECHNOLOGIES INC | $0 | – | -300,000 | -100.0% | -0.78% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -150,000 | -100.0% | -0.87% | – |
| CLLS | Exit | CELLECTIS - ADRsponsored ads | $0 | – | -75,000 | -100.0% | -0.89% | – |
| Exit | PTC THERAPEUTICS INCcall | $0 | – | -75,000 | -100.0% | -0.90% | – | |
| Exit | NEURODERM LTD | $0 | – | -100,000 | -100.0% | -0.93% | – | |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -65,000 | -100.0% | -0.94% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -55,000 | -100.0% | -0.98% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -120,000 | -100.0% | -1.00% | – |
| Exit | HERON THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -1.10% | – | |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -225,000 | -100.0% | -1.15% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -30,000 | -100.0% | -1.23% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -1.31% | – |
| Exit | THERAPEUTICSMD INCcall | $0 | – | -500,000 | -100.0% | -1.32% | – | |
| QURE | Exit | UNIQURE B.V. | $0 | – | -150,000 | -100.0% | -1.38% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.42% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -7,000 | -100.0% | -1.45% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -1.53% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -50,000 | -100.0% | -1.74% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -165,000 | -100.0% | -1.82% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -90,000 | -100.0% | -2.12% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -370,000 | -100.0% | -2.25% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -120,000 | -100.0% | -2.31% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -275,000 | -100.0% | -2.45% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -40,000 | -100.0% | -2.56% | – |
| FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -350,000 | -100.0% | -2.57% | – |
| Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -100,000 | -100.0% | -2.66% | – | |
| Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -75,000 | -100.0% | -2.71% | – | |
| CELG | Exit | CELGENE CORP | $0 | – | -60,000 | -100.0% | -2.92% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -70,000 | -100.0% | -3.09% | – |
| AGN | Exit | Allergan PLC | $0 | – | -37,500 | -100.0% | -4.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.